« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 4
, Pages 1029-1034
, 15 November 2009
Benefit of Radiation Boost After Whole-Breast Radiotherapy
References
- Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–1232
- Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241
- Survival and breast relapse in 3834 patients with T1–T2 breast cancer after conserving surgery and adjuvant treatment. Radiother Oncol. 2007;82:287–293
- . Effects of radiotherapy and differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomized trial. Lancet. 2004;366:2087–2106
- on behalf of the EORTC Radiation Oncology and Breast Cancer Groups The addition of a boost dose on the primary tumor bed after lumpectomy in breast conserving treatment for breast cancer. A summol/lary of the results of EORTC 22881–10882 “boost versus no boost” trial. Cancer Radiother. 2008;12:565–570
- on behalf of the EORTC Radiation Oncology and Breast Cancer Groups. Impact of the boost dose of 10Gy versus 26Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-Year results of the randomised EORTC boost trial. Radiother Oncol. 2009;90:80–85
- Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 1992;84:683–689
- . Sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Natl Cancer Inst. 1990;82:277–282
- Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France. J Clin Oncol. 1997;15:963–968
- Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I–II breast cancer: First results of the randomized Budapest boost trial. Strahlenther Onkol. 2002;178:615–623
- Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 2001;345:1378–1387
- International Commol/lission of Radiation Units and Measurements: Dose specification for reporting external beam therapy with photons and electrons. Report 50. Bethesda, MD: ICU; 1992;
- Ten-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol. 1999;17:2326–2333
- Randomised controlled trial of conservation therapy for breast cancer: 6-Year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet. 1996;348:708–713
- Austrian Breast and Colorectal Cancer Study Group. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys. 2007;68:334–340
- Tumor bed boost omission after negative re-excision in breast-conservation treatment. Ann Surg Oncol. 2006;13:794–801
- . Placing the boost in breast-conservation radiotherapy: A review of the role, indications and techniques for breast-boost radiotherapy. Clin Oncol. 2006;18:210–219
- . Role of 10-Gy boost radiation after breast-conserving surgery for stage I–II breast cancer with a 5-mm negative margin. Int J Clin Oncol. 2007;12:261–267
- . Adjuvant therapy of the very young woman. Breast. 2007;16(Suppl 2):S136–S146
- To boost the tumor bed: The age of reason. Cancer Radiother. 2004;8:33–38
- EORTC Radiotherapy, Breast Cancer Groups. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?. Eur J Cancer. 2003;39:932–944
- Impact of higher radiation dose on local control and survival in breast conserving therapy of early breast cancer: 10-Year results of the randomized boost versus no boost EORTC 22881-10883 trial. J Clin Oncol. 2007;25:3259–3265
- Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol. 2007;82:265–271
- Risk factors of local relapse in breast cancer: The importance of age. Clin Transl Oncol. 2007;9:110–116
- DEGRO practical guidelines for radiotherapy of breast cancer I: Breast-conserving therapy. Strahlenther Onkol. 2007;183:661–666
- Carlson RW, Allred DC, Anderson BO, et al. NCCN Practice Guidelines in Oncology—v.1 2009 Breast Cancer. Available at: www.nccn.org.
- Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy. Cancer. 2003;97:30–39
- Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy. Oncol Rep. 2007;18:1335–1339
Conflict of interest: none.
PII: S0360-3016(09)00025-X
doi: 10.1016/j.ijrobp.2008.12.038
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 4
, Pages 1029-1034
, 15 November 2009
